Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antigen
Biotech
Merck pens $300M-per-drug collab to find hidden tumor antigens
Merck & Co. has penned a $300 million biobucks-per-product deal to identify previously secret antigens for off-the-shelf cancer immunotherapies.
James Waldron
Feb 19, 2025 7:00am
FDA issues first full clearance for a rapid antigen COVID test
Mar 9, 2023 11:04am
Roche rebrands rapid COVID test as it heads to US store shelves
Nov 10, 2022 12:38pm
FDA urges repeated antigen tests when COVID screening at home
Aug 12, 2022 11:39am
FDA cracks down on use of unauthorized LuSys COVID tests
Jan 12, 2022 9:40am
Roche nets U.S. green light for rapid, home-based COVID test
Dec 28, 2021 9:41am
